Drug Profile
Research programme: hypersensitivity LAMP vaccines - Immunomic Therapeutics
Alternative Names: Multi allergen vaccine - Immunomic; MULTI-LAMP-vaxLatest Information Update: 28 Apr 2021
Price :
$50
*
At a glance
- Originator Immunomic Therapeutics
- Developer Astellas Pharma; Immunomic Therapeutics
- Class DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hypersensitivity
Most Recent Events
- 28 Apr 2021 No recent reports of development identified for preclinical development in Allergy(Prevention) in USA
- 28 Jan 2021 No recent reports of development identified for preclinical development in Allergy in USA
- 03 Mar 2017 Preclinical trials in Hypersensitivity (Prevention) in USA (unspecified route)